---
figid: PMC7270402__fimmu-11-01037-g0001
figlink: pmc/articles/PMC7270402/figure/F1/
number: Figure 1
caption: The immune landscape of the HBV-based tumor microenvironment. Under virus
  infection conditions, the immune status of an HCC-bearing host becomes more immunosuppressive
  and is characterized by weakening of co-stimulatory signal, enhancement of co-inhibitory
  signals, functional impairment, decreased quantity of tumor-killing T cells, such
  as CD8+ and enrichment of Tregs. Therein, the PD-1/PD-L1 pathway plays a suppressive
  role to produce cancer immune escape, while the LAG3/MHC-II, Tim-3/galectin 9, and
  CTLA-4/(CD80, CD86) pathways also contribute to this process. This figure was drawn
  with Adobe Illustrator CS5. TCR, T-cell receptor; MHC, major histocompatibility
  complex; APC, antigen-presenting cell; PD-1, programmed cell death protein 1; PD-L1,
  programmed death-ligand 1; CTLA-4, cytotoxic T lymphocyte associated antigen-4;
  Tim-3, T-cell immunoglobulin and mucin domain-3; LAG3, lymphocyte activation gene
  3; TGF-β, transforming growth factor beta.
pmcid: PMC7270402
papertitle: 'Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis
  B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review.'
reftext: Bin Li, et al. Front Immunol. 2020;11:1037.
pmc_ranked_result_index: '92603'
pathway_score: 0.6592156
filename: fimmu-11-01037-g0001.jpg
figtitle: Immune landscape of the HBV-based tumor microenvironment
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7270402__fimmu-11-01037-g0001.html
  '@type': Dataset
  description: The immune landscape of the HBV-based tumor microenvironment. Under
    virus infection conditions, the immune status of an HCC-bearing host becomes more
    immunosuppressive and is characterized by weakening of co-stimulatory signal,
    enhancement of co-inhibitory signals, functional impairment, decreased quantity
    of tumor-killing T cells, such as CD8+ and enrichment of Tregs. Therein, the PD-1/PD-L1
    pathway plays a suppressive role to produce cancer immune escape, while the LAG3/MHC-II,
    Tim-3/galectin 9, and CTLA-4/(CD80, CD86) pathways also contribute to this process.
    This figure was drawn with Adobe Illustrator CS5. TCR, T-cell receptor; MHC, major
    histocompatibility complex; APC, antigen-presenting cell; PD-1, programmed cell
    death protein 1; PD-L1, programmed death-ligand 1; CTLA-4, cytotoxic T lymphocyte
    associated antigen-4; Tim-3, T-cell immunoglobulin and mucin domain-3; LAG3, lymphocyte
    activation gene 3; TGF-β, transforming growth factor beta.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD8A
  - CD8B
  - NELFCD
  - CLU
  - AKR1C4
  - C2
  - TRA
  - TRB
  - TRD
  - TRG
  - PDCD1
  - CTLA4
  - LAG3
  - IL2RA
  - IL10
  - CD28
  - APC
  - HAVCR2
  - CD274
  - TGFB1
  - TGFB2
  - TGFB3
  - CD86
  - CD80
  - IL2
  - TCR
  - TCR TCR
genes:
- word: CD8+
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: CD8+
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: Th1
  symbol: TH1
  source: hgnc_alias_symbol
  hgnc_symbol: NELFCD
  entrez: '51497'
- word: cll
  symbol: CLI
  source: hgnc_prev_symbol
  hgnc_symbol: CLU
  entrez: '1191'
- word: cll
  symbol: C11
  source: hgnc_alias_symbol
  hgnc_symbol: AKR1C4
  entrez: '1109'
- word: cll
  symbol: C2
  source: hgnc_symbol
  hgnc_symbol: C2
  entrez: '717'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: CD8+
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: CD8+
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: LAG3
  symbol: LAG3
  source: hgnc_symbol
  hgnc_symbol: LAG3
  entrez: '3902'
- word: Th1
  symbol: TH1
  source: hgnc_alias_symbol
  hgnc_symbol: NELFCD
  entrez: '51497'
- word: IL-2R
  symbol: IL2R
  source: hgnc_prev_symbol
  hgnc_symbol: IL2RA
  entrez: '3559'
- word: •IL-10
  symbol: IL10
  source: hgnc_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: IL-10
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Tim-3
  symbol: Tim-3
  source: hgnc_alias_symbol
  hgnc_symbol: HAVCR2
  entrez: '84868'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: CD86
  symbol: CD86
  source: hgnc_symbol
  hgnc_symbol: CD86
  entrez: '942'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: LAG3
  symbol: LAG3
  source: hgnc_symbol
  hgnc_symbol: LAG3
  entrez: '3902'
- word: CD80
  symbol: CD80
  source: hgnc_symbol
  hgnc_symbol: CD80
  entrez: '941'
- word: CD80
  symbol: CD80
  source: hgnc_symbol
  hgnc_symbol: CD80
  entrez: '941'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: АРС
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: IL-2R
  symbol: IL2R
  source: hgnc_prev_symbol
  hgnc_symbol: IL2RA
  entrez: '3559'
- word: IL-2
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
- word: TCR TCR
  source: MESH
  identifier: D017260
diseases: []
---
